专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

31. 发明授权

US07576221B2 Substituted imidazole derivatives 有权
公开(公告)号：US07576221B2
公开(公告)日：2009-08-18
申请号：US11158574
申请日：2005-06-20
申请人： Weibo Wang , Paul A. Barsanti , Yia Xia , Rustum Boyce , Sabina Pecchi , Nathan Brammeier , Megan C. Phillips , Kris Mendenhall , Kelly Wayman , Liana Marie Lagniton , Ryan Constantine , Hong Yang , Elizabeth Mieuli , Savithri Ramurthy , Elisa Jazan , Anu Sharma , Rama Jain , Sharadha Subramanian , Paul A. Renhowe , Kenneth W. Bair , David Duhl , Annette Walter , Tinya Abrams , Kay Huh , Eric Martin , Mark Knapp , Vincent P. Le
发明人： Weibo Wang , Paul A. Barsanti , Yia Xia , Rustum Boyce , Sabina Pecchi , Nathan Brammeier , Megan C. Phillips , Kris Mendenhall , Kelly Wayman , Liana Marie Lagniton , Ryan Constantine , Hong Yang , Elizabeth Mieuli , Savithri Ramurthy , Elisa Jazan , Anu Sharma , Rama Jain , Sharadha Subramanian , Paul A. Renhowe , Kenneth W. Bair , David Duhl , Annette Walter , Tinya Abrams , Kay Huh , Eric Martin , Mark Knapp , Vincent P. Le
IPC分类号： A61K31/4174 , C07D233/64
CPC分类号： C07D233/54 , C07D233/24 , C07D233/64 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/06 , C07D405/12 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , C07D498/10
摘要： The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:

32. 发明申请

US20090171082A1 MITOTIC KINESIN INHIBITORS 审中-公开
公开(公告)号：US20090171082A1
公开(公告)日：2009-07-02
申请号：US12398118
申请日：2009-03-04
申请人： Weibo Wang , Ryan Constantine , Liana Lagniton
发明人： Weibo Wang , Ryan Constantine , Liana Lagniton
IPC分类号： C07D471/04
CPC分类号： C07D471/04 , C07D239/36
摘要： The present invention relates to compounds that are useful for treating cellular proliferative diseases, for treating disorders mediated, at least in part, by KSP, and for inhibiting KSP. The invention also related to pharmaceutical compositions comprising such compounds, methods of treating cancer by the administration of such compositions, and processes for the preparation of the compounds. Compounds of the invention have the following formula:
摘要翻译：本发明涉及可用于治疗细胞增殖性疾病，用于治疗至少部分由KSP介导的病症和用于抑制KSP的化合物。本发明还涉及包含这些化合物的药物组合物，通过施用这些组合物治疗癌症的方法，以及制备化合物的方法。本发明化合物具有下式：

33. 发明申请

US20080207589A1 CYCLIZED DERIVATIVES AS EG-5 INHIBITORS 失效
标题翻译：循环衍生物作为EG-5抑制剂
公开(公告)号：US20080207589A1
公开(公告)日：2008-08-28
申请号：US11969164
申请日：2008-01-03
申请人： Rustum Boyce , Eric Martin , Weibo Wang , Hong Yang , Paul A. Barsanti
发明人： Rustum Boyce , Eric Martin , Weibo Wang , Hong Yang , Paul A. Barsanti
IPC分类号： A61K31/553 , C07D403/02 , C07D413/02 , A61K31/5377 , A61K31/422 , C12N9/99 , A61P35/00 , C12N5/00 , A61K31/4164 , A61K31/496 , A61K31/5513 , C07D233/61
CPC分类号： C07D403/06 , C07D413/06
摘要： The present invention relates to new substituted imidazole compounds have the following Formula (I) and to the pharmaceutically acceptable salts, esters, or prodrugs thereof, to compositions of the compounds together with pharmaceutically acceptable carriers, and to uses of the compounds:
摘要翻译：本发明涉及具有下式（I）的新的取代咪唑化合物及其药学上可接受的盐，酯或前药与化合物与药学上可接受的载体的组合物，以及该化合物的用途：

34. 发明申请

US20080069817A1 HETEROARYL-FUSED PYRIMIDINYL COMPOUNDS AS ANTICANCER AGENTS 审中-公开
标题翻译：作为反应剂代谢物的异氟醚化的吡咯烷酮化合物
公开(公告)号：US20080069817A1
公开(公告)日：2008-03-20
申请号：US11863048
申请日：2007-09-27
申请人： Weibo Wang , Liana Lagniton , Ryan Constantine , Matthew Burger
发明人： Weibo Wang , Liana Lagniton , Ryan Constantine , Matthew Burger
IPC分类号： A61K39/395 , A61K31/496 , A61K31/4985 , A61K31/519 , C07D239/70 , A61P35/00 , A61K31/65 , A61K31/66
CPC分类号： C07D239/88 , C07D495/04 , Y10S435/81
摘要： Heteroaryl-fused pyrimidinyl compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the heteroaryl-fused pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the heteroaryl-fused pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
摘要翻译：杂芳基稠合的嘧啶基化合物，其药学上可接受的盐和前药; 包括药学上可接受的载体和一种或多种杂芳基稠合的嘧啶基化合物的组合物，单独或与至少一种另外的治疗剂组合。将杂芳基稠合的嘧啶基化合物单独使用或与至少一种另外的治疗剂组合使用在预防或治疗增殖性疾病中的方法。

35. 发明授权

US07345046B2 Heteroaryl-fused pyrimidinyl compounds as anticancer agents 失效
标题翻译：杂芳基稠合嘧啶基化合物作为抗癌剂
公开(公告)号：US07345046B2
公开(公告)日：2008-03-18
申请号：US10850429
申请日：2004-05-21
申请人： Weibo Wang , Liana Marie Lagniton , Ryan N. Constantine , Matthew T. Burger
发明人： Weibo Wang , Liana Marie Lagniton , Ryan N. Constantine , Matthew T. Burger
IPC分类号： A61K31/519 , A61K31/13 , A61K33/24 , A61K33/42 , A61K39/395 , A61K31/337 , A61K31/497 , A61K31/436 , A61K31/506 , A61K31/555 , C07D495/04 , A61P35/04
CPC分类号： C07D239/88 , C07D495/04 , Y10S435/81
摘要： Heteroaryl-fused pyrimidinyl compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the heteroaryl-fused pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the heteroaryl-fused pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
摘要翻译：杂芳基稠合的嘧啶基化合物，其药学上可接受的盐和前药; 包括药学上可接受的载体和一种或多种杂芳基稠合的嘧啶基化合物的组合物，单独或与至少一种另外的治疗剂组合。将杂芳基稠合的嘧啶基化合物单独使用或与至少一种另外的治疗剂组合使用在预防或治疗增殖性疾病中的方法。

36. 发明申请

US20050085490A1 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents 失效
标题翻译：吡啶并[1,2-a]嘧啶-4-酮化合物作为抗癌剂
公开(公告)号：US20050085490A1
公开(公告)日：2005-04-21
申请号：US10870707
申请日：2004-06-17
申请人： Weibo Wang , Ryan Constantine , Liana Lagniton , Sabina Pecchi , Matthew Burger , Manoj Desai
发明人： Weibo Wang , Ryan Constantine , Liana Lagniton , Sabina Pecchi , Matthew Burger , Manoj Desai
IPC分类号： A61K31/519 , A61P35/00 , C07D471/04 , C07D487/04
CPC分类号： C07D471/04
摘要： Pyridin[1,2-a]pyrimidinyl compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the pyridino[1,2-a]pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the pyridino[1,2-a]pyrimidinyl compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
摘要翻译：吡啶并[1,2-a]嘧啶基化合物，其药学上可接受的盐和前药; 包括药学上可接受的载体和一种或多种吡啶并[1,2-a]嘧啶基化合物的组合物，单独或与至少一种另外的治疗剂组合。单独或与至少一种其它治疗剂组合使用吡啶并[1,2-a]嘧啶基化合物在预防或治疗增殖性疾病中的方法。

37. 发明授权

US09646336B2 Information processing system and information processing method 有权
公开(公告)号：US09646336B2
公开(公告)日：2017-05-09
申请号：US14197311
申请日：2014-03-05
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： G06Q30/06 , G06Q10/08
CPC分类号： G06Q30/0627 , G06Q10/0875
摘要： An information processing system constituted with one or more computers includes a first result storage part to store result values of operation amounts of a first device; a prediction part to generate prediction values of operation amounts of the first device during a period; a calculation part to calculate indicator values based on the prediction values; an extraction part to select a second device that substitutes the first device using the indicator values; a replacement information storage part to store correspondence information between a device before replacement and a device after replacement; an obtainment part to obtain operation amounts of the devices before and after replacement, respectively, assuming that the first device is replaced by the second device; and an output part to output information about the obtained operation amounts.

38. 发明授权

US09229669B2 Device control system, device controller, and device control method 有权
标题翻译：设备控制系统，设备控制器和设备控制方法
公开(公告)号：US09229669B2
公开(公告)日：2016-01-05
申请号：US14644483
申请日：2015-03-11
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： G06F15/00 , G06F3/12 , G06K1/00
CPC分类号： G06F3/1236 , G06F3/1203 , G06F3/1221 , G06F3/1229 , G06F3/1285 , G06F3/1287 , G06Q10/06 , Y02D10/1592
摘要： A device control system provided herein includes: a reservation unit that receives inputs of location identification information, a use date/time, and user identification information and makes a reservation so that a user can use a location and a device disposed at the location at the use date/time; a determination unit that acquires user position information and location position information and determines whether or not a predetermined relationship is established between the position of the user and position of the location within a first time period before start of the use date/time; a control information generation unit that acquires device information including at least device identification information for identifying the device on a network and uses the acquired device information to generate control information for controlling operation of the device; and a device control unit that controls operation of the device using the control information when the predetermined relationship is established.
摘要翻译：本文提供的设备控制系统包括：预留单元，其接收位置识别信息的输入，使用日期/时间和用户识别信息，并进行预约，使得用户可以使用位于该位置处的位置和设备处的设备使用日期/时间; 确定单元，其获取用户位置信息和位置位置信息，并且确定在使用日期/时间开始之前的第一时间段内在用户的位置和位置的位置之间是否建立预定关系; 控制信息生成单元，其获取至少包括用于识别网络上的设备的设备识别信息的设备信息，并使用所获取的设备信息来生成用于控制设备的操作的控制信息; 以及设备控制单元，其在建立所述预定关系时使用所述控制信息来控制所述设备的操作。

39. 发明授权

US08648073B2 Certain dipeptidyl peptidase inhibitors 有权
标题翻译：某些二肽基肽酶抑制剂
公开(公告)号：US08648073B2
公开(公告)日：2014-02-11
申请号：US12979571
申请日：2010-12-28
申请人： Weibo Wang , Tongshuang Li
发明人： Weibo Wang , Tongshuang Li
IPC分类号： A61K31/53 , C07D239/20
CPC分类号： C07D401/04
摘要： Provided are certain dipeptidyl peptidase inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
摘要翻译：提供某些二肽基肽酶抑制剂，其药物组合物及其用途的方法。

40. 发明授权

US08370469B2 Management device, management method, and recording medium for synchronizing information from management devices 有权
标题翻译：管理装置，管理方法和用于同步来自管理装置的信息的记录介质
公开(公告)号：US08370469B2
公开(公告)日：2013-02-05
申请号：US12585320
申请日：2009-09-11
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： G06F15/16
CPC分类号： H04L29/04 , G03G15/5079 , G03G15/55 , G03G15/553 , G03G2215/00109
摘要： A first acquisition unit acquires an event notification from an MFP and updates first device-status information. A transmission unit transmits the event notification and first reference-destination information. A switching unit switches a first access to the first reference-destination information to a second access to second reference-destination information. A second acquisition unit issues an acquisition request at a first interval, issues an acquisition request at a second interval in response to the event notification, acquires the second device-status information, and update the first device-status information.
摘要翻译：第一采集单元从MFP获取事件通知并更新第一设备状态信息。发送单元发送事件通知和第一参考目的地信息。切换单元将对第一参考目的地信息的第一访问切换到对第二参考目的地信息的第二访问。第二采集单元以第一间隔发出获取请求，响应于事件通知以第二间隔发出获取请求，获取第二设备状态信息，并更新第一设备状态信息。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式